Jazz Pharmaceuticals Wins FDA Approval For Two Advanced Gastric Cancer Regimens

기사 요약

FDA approves Jazz Pharmaceuticals' Ziihera combinations for first-line treatment of HER2-positive gastroesophageal adenocarcinoma.